These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 28617150)
1. Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks. Elmowafy M; Ibrahim HM; Ahmed MA; Shalaby K; Salama A; Hefesha H Drug Deliv; 2017 Nov; 24(1):932-941. PubMed ID: 28617150 [TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445 [TBL] [Abstract][Full Text] [Related]
3. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation. Dudhipala N; Janga KY; Gorre T Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077 [TBL] [Abstract][Full Text] [Related]
5. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol. Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044 [TBL] [Abstract][Full Text] [Related]
6. Chitosan-coated nanostructured lipid carriers of fenofibrate with enhanced oral bioavailability and efficacy. Pyo YC; Tran P; Kim DH; Park JS Colloids Surf B Biointerfaces; 2020 Dec; 196():111331. PubMed ID: 32906001 [TBL] [Abstract][Full Text] [Related]
7. Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects. Dong Z; Iqbal S; Zhao Z AAPS PharmSciTech; 2020 Jan; 21(2):64. PubMed ID: 31932990 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of S(+)-zaltoprofen oral bioavailability using nanostructured lipid carrier system. Pham TMA; Lee DH; Na YG; Jin M; Jung M; Kim HE; Yoo H; Won JH; Lee JY; Baek JS; Han SC; Lee HK; Cho CW Arch Pharm Res; 2022 Nov; 45(11):822-835. PubMed ID: 36307644 [TBL] [Abstract][Full Text] [Related]
9. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015 [TBL] [Abstract][Full Text] [Related]
10. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers. Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361 [TBL] [Abstract][Full Text] [Related]
11. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
12. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption. Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104 [TBL] [Abstract][Full Text] [Related]
13. Enhanced Oral Absorption of Amisulpride Via a Nanostructured Lipid Carrier-Based Capsules: Development, Optimization Applying the Desirability Function Approach and In Vivo Pharmacokinetic Study. El Assasy AEI; Younes NF; Makhlouf AIA AAPS PharmSciTech; 2019 Jan; 20(2):82. PubMed ID: 30652198 [TBL] [Abstract][Full Text] [Related]
14. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy: Abd-Elhakeem E; El-Nabarawi M; Shamma R Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445 [TBL] [Abstract][Full Text] [Related]
15. Quality by design (QbD)-based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies. Gurumukhi VC; Bari SB Drug Deliv Transl Res; 2022 May; 12(5):1230-1252. PubMed ID: 34110597 [TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability. Teng Z; Yu M; Ding Y; Zhang H; Shen Y; Jiang M; Liu P; Opoku-Damoah Y; Webster TJ; Zhou J Int J Nanomedicine; 2019; 14():119-133. PubMed ID: 30613141 [TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: In vitro, cell line and in vivo evaluation. Patel P; Patel M Eur J Pharm Sci; 2021 Apr; 159():105715. PubMed ID: 33453388 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Study of Atorvastatin Nanostructured Lipid Carriers through Multivariate Conceptualization and Optimization. Ghanem HA; Nasr AM; Hassan TH; Elkhoudary MM; Alshaman R; Alattar A; Gad S Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33525642 [TBL] [Abstract][Full Text] [Related]
19. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation. Shehata MK; Ismail AA; Kamel MA Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692 [TBL] [Abstract][Full Text] [Related]
20. Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects. Shi F; Wei Z; Zhao Y; Xu X Pharmacogn Mag; 2016; 12(47):198-202. PubMed ID: 27601850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]